NABI BIOPHARMACEUTICALS 4
4 · NABI BIOPHARMACEUTICALS · Filed Jan 24, 2008
Insider Transaction Report
Form 4
FAHIM RAAFAT E F
DirectorPresident, CEO and CFO
Transactions
- Award
Common Stock
2008-01-22+50,000→ 176,730.422 total - Award
Common Stock
[F1]2008-01-22+7,000→ 183,730.422 total
Footnotes (1)
- [F1]Restricted Stock that vests in full on January 22, 2009.
Signature
/s/ James E. Dawson, as attorney-in-fact|2008-01-24